Cargando…

Impact of exacerbations of cystic fibrosis on muscle strength

BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burtin, Chris, Van Remoortel, Hans, Vrijsen, Bart, Langer, Daniel, Colpaert, Kristine, Gosselink, Rik, Decramer, Marc, Dupont, Lieven, Troosters, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637497/
https://www.ncbi.nlm.nih.gov/pubmed/23601143
http://dx.doi.org/10.1186/1465-9921-14-46
_version_ 1782267486872272896
author Burtin, Chris
Van Remoortel, Hans
Vrijsen, Bart
Langer, Daniel
Colpaert, Kristine
Gosselink, Rik
Decramer, Marc
Dupont, Lieven
Troosters, Thierry
author_facet Burtin, Chris
Van Remoortel, Hans
Vrijsen, Bart
Langer, Daniel
Colpaert, Kristine
Gosselink, Rik
Decramer, Marc
Dupont, Lieven
Troosters, Thierry
author_sort Burtin, Chris
collection PubMed
description BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. METHODS: QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. RESULTS: QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). CONCLUSIONS: QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity.
format Online
Article
Text
id pubmed-3637497
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36374972013-04-27 Impact of exacerbations of cystic fibrosis on muscle strength Burtin, Chris Van Remoortel, Hans Vrijsen, Bart Langer, Daniel Colpaert, Kristine Gosselink, Rik Decramer, Marc Dupont, Lieven Troosters, Thierry Respir Res Research BACKGROUND: Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. METHODS: QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. RESULTS: QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). CONCLUSIONS: QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity. BioMed Central 2013 2013-04-19 /pmc/articles/PMC3637497/ /pubmed/23601143 http://dx.doi.org/10.1186/1465-9921-14-46 Text en Copyright © 2013 Burtin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Burtin, Chris
Van Remoortel, Hans
Vrijsen, Bart
Langer, Daniel
Colpaert, Kristine
Gosselink, Rik
Decramer, Marc
Dupont, Lieven
Troosters, Thierry
Impact of exacerbations of cystic fibrosis on muscle strength
title Impact of exacerbations of cystic fibrosis on muscle strength
title_full Impact of exacerbations of cystic fibrosis on muscle strength
title_fullStr Impact of exacerbations of cystic fibrosis on muscle strength
title_full_unstemmed Impact of exacerbations of cystic fibrosis on muscle strength
title_short Impact of exacerbations of cystic fibrosis on muscle strength
title_sort impact of exacerbations of cystic fibrosis on muscle strength
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637497/
https://www.ncbi.nlm.nih.gov/pubmed/23601143
http://dx.doi.org/10.1186/1465-9921-14-46
work_keys_str_mv AT burtinchris impactofexacerbationsofcysticfibrosisonmusclestrength
AT vanremoortelhans impactofexacerbationsofcysticfibrosisonmusclestrength
AT vrijsenbart impactofexacerbationsofcysticfibrosisonmusclestrength
AT langerdaniel impactofexacerbationsofcysticfibrosisonmusclestrength
AT colpaertkristine impactofexacerbationsofcysticfibrosisonmusclestrength
AT gosselinkrik impactofexacerbationsofcysticfibrosisonmusclestrength
AT decramermarc impactofexacerbationsofcysticfibrosisonmusclestrength
AT dupontlieven impactofexacerbationsofcysticfibrosisonmusclestrength
AT troostersthierry impactofexacerbationsofcysticfibrosisonmusclestrength